1-3
2026
影响因子区间
—
平台估算
0%
2025
中国作者发文占比
40000000 IRR;600 USD
收费
期刊简介:This journal aims to review the most important, recently published treatment-related advances in cardiovascular medicine. By providing clear, insightful, balanced contributions by international experts, the journal intends to elucidate novel approaches to treatment in those affected by the spectrum of cardiovascular-related diseases and conditions. We accomplish this aim by appointing international authorities to serve as Section Editors in key subject areas, such as coronary artery disease, cerebrovascular disease and stroke, heart failure, pediatric and congenital heart disease, and valvular, myocardial, pericardial, and cardiopulmonary diseases. Section Editors, in turn, select topics for which leading experts contribute comprehensive review articles that emphasize new developments and recently published papers of major importance, highlighted by annotated reference lists. We also provide commentaries from well-known figures in the field, and an international Editorial Board reviews the annual table of contents, suggests articles of special interest to their country/region, and ensures that topics are current and include emerging research.
【译文】本期刊旨在回顾心血管医学领域最近发表的重要治疗相关进展。通过提供国际专家清晰、深入、平衡的贡献,该期刊旨在阐明受心血管相关疾病和条件影响的人的治疗新方法。我们通过任命国际权威人士担任关键领域的部门编辑,如冠状动脉疾病、脑血管疾病和卒中、心力衰竭、儿科和先天性心脏病,以及瓣膜、心肌、心包和心肺疾病,来实现这一目标。部门编辑随后选择主题,由领先的专家撰写全面综述文章,强调新发展和新发表的具有重大重要性的论文,并附有注释参考文献列表。我们还提供来自该领域知名人士的评论,国际编委会审查年度目录,建议对其国家/地区特别感兴趣的文章,并确保主题是当前的,包括新兴研究。

| 指标 | 当前值 | 近三年趋势 |
|---|---|---|
| JCR分区 | Q4 | 暂无 |
| 影响因子区间 | 1-3 | 暂无 |